Business
Telix (ASX:TLX) share price down 4% despite new deal
Biopharma Telix Pharmaceuticals Ltd (ASX: TLX) share price is trading lower this morning, despite the company announcing the completion of its acquisition of Swiss-based company, TheraPharm.
At the same time, the company also announced that TheraPharm has now completed an intellectual property (IP) agreement with the University of Southampton in the United Kingdom.
At the time of writing, the Telix share price is trading at $3.59, down 4.27%.
About the TheraPharm acquisition
Telix advised it has now acquired all of the issued capital of TheraPharm for the final upfront consideration of €10.2 million (A$16.5 million). This was done at a price of $3.75 per share. That deal was first announced in late November.
Telix also…
-
Noosa News24 hours agoHow a 3D printed aorta helped surgeons replace a ‘ticking time bomb’ inside a man’s chest
-
Noosa News21 hours agoEnsure voices are heard – Proctor
-
General22 hours agoReserve Bank board still looking for yesterday’s news
-
Noosa News16 hours agoMajor crash on Gateway Motorway snarls morning commute